NCT04705610
Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography No drug interventions other Not Available completed NCT05177523
Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis No drug interventions Not Available Not Available recruiting NCT01804647
Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease No drug interventions Not Available Not Available completed NCT01848327
Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis No drug interventions treatment Not Available completed NCT06436131
The Effects of In-phase Bilateral Exercise in People with Progressive Multiple Sclerosis No drug interventions treatment Not Available completed NCT02305264
Imaging of Intracerebral Inflammation in MS diagnostic Not Available completed NCT06526364
Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland) No drug interventions Not Available Not Available not_yet_recruiting NCT05359653
Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy treatment 1 / 2 recruiting NCT05663853
An Observational Biomarker Study in Multiple Sclerosis (MS) Patients No drug interventions Not Available Not Available completed NCT01433497
Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis treatment 3 completed NCT01982942
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis treatment 2 completed NCT04918225
Motor Asymmetry in Progressive Multiple Sclerosis Patients No drug interventions Not Available Not Available recruiting NCT03679468
Improving Cognition in People With Progressive Multiple Sclerosis Using Aerobic Exercise and Cognitive Rehabilitation No drug interventions other Not Available completed NCT02506751
Open-label Study of Liothyronine in MS treatment 1 completed NCT04035005
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis treatment 3 recruiting NCT02688985
Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS) treatment 3 completed NCT06138132
A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis treatment 1 recruiting NCT05122559
Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis treatment 2 recruiting NCT05204459
MS-ResearchBiomarkerS No drug interventions Not Available Not Available recruiting NCT01194570
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis treatment 3 completed NCT04544449
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis treatment 3 active_not_recruiting NCT01917019
A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis treatment 3 completed NCT02913157
Hydroxychloroquine in Primary Progressive Multiple Sclerosis treatment 2 completed NCT03455582
Cognition Evolution and MRI Markers in PPMS Patients on 2 Years No drug interventions diagnostic Not Available recruiting NCT05385731
MUSCLE - Nordic Walking in MUltiple SCLErosis No drug interventions treatment Not Available not_yet_recruiting NCT06384976
A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis No drug interventions treatment 2 not_yet_recruiting NCT02988401
Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis treatment 1 / 2 completed NCT04545372
Aerobic Exercises for Multiple Sclerosis No drug interventions treatment Not Available completed NCT05496881
Exercise Effects in Multiple Sclerosis No drug interventions supportive_care Not Available recruiting NCT04550650
Follow-up Study of the Effectiveness of Virtual Reality Therapy in MS Patients No drug interventions treatment Not Available completed NCT03424538
The Effect of Neurorehabilitation Therapy on Postural Control, Mobility and Quality of Life in Multiple Sclerosis Patients No drug interventions treatment Not Available completed NCT02606929
Use of Well Known Drugs for New Destination - MS Improvement (MSNT) Not Available 0 temporarily_not_available NCT02632591
Use on Human Beings of Mix of Known Drugs for New Destination - MS Treatment treatment 1 completed NCT05974839
Effect of Ocrelizumab on Cortical Lesion Accumulation in Patients With PPMS (ORATORIO-Cortical) No drug interventions Not Available Not Available completed NCT03094364
Video Game-based Therapy for Arm Weakness In Progressive Multiple Sclerosis No drug interventions treatment Not Available completed NCT02549703
Mitochondrial Dysfunction and Disease Progression No drug interventions Not Available Not Available completed NCT03783416
SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis No drug interventions other 1 recruiting NCT03691077
Effect of Ocrelizumab on Brain Innate Immune Microglial Cells Activation in MS Using PET-MRI With 18F-DPA714 treatment 3 recruiting NCT03562975
Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus Not Available Not Available active_not_recruiting NCT03493841
Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis treatment 1 completed NCT05229861
The Influence of HIIT Versus MCT on Cardiorespiratory Fitness in PPMS No drug interventions treatment Not Available unknown_status NCT01950234
ACTH in Progressive Forms of MS treatment 2 terminated NCT01854359
Idebenone for Primary Progressive Multiple Sclerosis treatment 1 / 2 completed NCT01191996
Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis No drug interventions treatment 1 / 2 completed NCT05974852
Effect of Ocrelizumab on Choroid Plexus Changes in Patients With PPMS No drug interventions Not Available Not Available active_not_recruiting NCT05349474
Metformin Treatment in Progressive Multiple Sclerosis treatment 0 recruiting NCT04943289
Intrathecal Administration of DUOC-01 in Adults With Primary Progressive Multiple Sclerosis No drug interventions treatment 1 recruiting NCT04458051
Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS) treatment 3 recruiting NCT04688788
Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis treatment 3 active_not_recruiting NCT04634994
Novel Assessment of Synaptic Density in Progressive MS No drug interventions diagnostic 0 unknown_status NCT05029609
Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MS treatment 1 withdrawn NCT03362294
Safety and Efficacy of Monthly Long-acting IM Injection of 25mg or 40 mg GA Depot in Subjects With PPMS No drug interventions treatment 2 active_not_recruiting NCT03283826
Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis No drug interventions treatment 1 / 2 terminated NCT02253264
A Phase 1 Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients treatment 1 completed NCT01466114
Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition treatment 2 unknown_status NCT04977622
Gray Matter Demyelination in Primary Progressive MS at 7T No drug interventions Not Available Not Available recruiting NCT05232825
A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis treatment 3 active_not_recruiting NCT05893225
Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration treatment 2 recruiting NCT02959658
Dimethyl Fumarate Treatment of Primary Progressive Multiple Sclerosis treatment 2 completed NCT02284568
A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo treatment 2 completed NCT02273635
Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS treatment 1 / 2 unknown_status NCT02208050
A Study of the Effectiveness of Fampridine in Improving Upper Limb Function in MS treatment 4 completed NCT02016222
Tear Analysis in the Diagnosis of Multiple Sclerosis No drug interventions diagnostic Not Available completed NCT01776060
Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK Study No drug interventions Not Available Not Available completed NCT01077466
Natalizumab Treatment of Progressive Multiple Sclerosis treatment 2 completed NCT00950248
Clinical Trial of Idebenone in Primary Progressive Multiple Sclerosis (IPPoMS) treatment 1 / 2 completed NCT00731692
This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS. treatment 3 terminated NCT01779934
OL, Single-arm Extension Study to the Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5 mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis treatment 3 completed